Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA

<p>Abstract</p> <p>Background</p> <p>Current methods for measurement of copy number do not combine all the desirable qualities of convenience, throughput, economy, accuracy and resolution. In this study, to improve the throughput associated with Multiplex Amplifiable Pr...

Full description

Bibliographic Details
Main Authors: Chan Alan, Wu Ying, Datta Parikkhit, Gibbons Brian, AL Armour John
Format: Article
Language:English
Published: BMC 2006-06-01
Series:BMC Genomics
Online Access:http://www.biomedcentral.com/1471-2164/7/163
_version_ 1819033582223491072
author Chan Alan
Wu Ying
Datta Parikkhit
Gibbons Brian
AL Armour John
author_facet Chan Alan
Wu Ying
Datta Parikkhit
Gibbons Brian
AL Armour John
author_sort Chan Alan
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Current methods for measurement of copy number do not combine all the desirable qualities of convenience, throughput, economy, accuracy and resolution. In this study, to improve the throughput associated with Multiplex Amplifiable Probe Hybridisation (MAPH) we aimed to develop a modification based on the 3-Dimensional, Flow-Through Microarray Platform from PamGene International. In this new method, electrophoretic analysis of amplified products is replaced with photometric analysis of a probed oligonucleotide array. Copy number analysis of hybridised probes is based on a dual-label approach by comparing the intensity of Cy3-labelled MAPH probes amplified from test samples co-hybridised with similarly amplified Cy5-labelled reference MAPH probes. The key feature of using a hybridisation-based end point with MAPH is that discrimination of amplified probes is based on sequence and not fragment length.</p> <p>Results</p> <p>In this study we showed that microarray MAPH measurement of <it>PMP22 </it>gene dosage correlates well with <it>PMP22 </it>gene dosage determined by capillary MAPH and that copy number was accurately reported in analyses of DNA from 38 individuals, 12 of which were known to have Charcot-Marie-Tooth disease type 1A (CMT1A).</p> <p>Conclusion</p> <p>Measurement of microarray-based endpoints for MAPH appears to be of comparable accuracy to electrophoretic methods, and holds the prospect of fully exploiting the potential multiplicity of MAPH. The technology has the potential to simplify copy number assays for genes with a large number of exons, or of expanded sets of probes from dispersed genomic locations.</p>
first_indexed 2024-12-21T07:20:08Z
format Article
id doaj.art-938606ad44dc4f0ca8f600823e496494
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-12-21T07:20:08Z
publishDate 2006-06-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-938606ad44dc4f0ca8f600823e4964942022-12-21T19:11:48ZengBMCBMC Genomics1471-21642006-06-017116310.1186/1471-2164-7-163Microarray MAPH: accurate array-based detection of relative copy number in genomic DNAChan AlanWu YingDatta ParikkhitGibbons BrianAL Armour John<p>Abstract</p> <p>Background</p> <p>Current methods for measurement of copy number do not combine all the desirable qualities of convenience, throughput, economy, accuracy and resolution. In this study, to improve the throughput associated with Multiplex Amplifiable Probe Hybridisation (MAPH) we aimed to develop a modification based on the 3-Dimensional, Flow-Through Microarray Platform from PamGene International. In this new method, electrophoretic analysis of amplified products is replaced with photometric analysis of a probed oligonucleotide array. Copy number analysis of hybridised probes is based on a dual-label approach by comparing the intensity of Cy3-labelled MAPH probes amplified from test samples co-hybridised with similarly amplified Cy5-labelled reference MAPH probes. The key feature of using a hybridisation-based end point with MAPH is that discrimination of amplified probes is based on sequence and not fragment length.</p> <p>Results</p> <p>In this study we showed that microarray MAPH measurement of <it>PMP22 </it>gene dosage correlates well with <it>PMP22 </it>gene dosage determined by capillary MAPH and that copy number was accurately reported in analyses of DNA from 38 individuals, 12 of which were known to have Charcot-Marie-Tooth disease type 1A (CMT1A).</p> <p>Conclusion</p> <p>Measurement of microarray-based endpoints for MAPH appears to be of comparable accuracy to electrophoretic methods, and holds the prospect of fully exploiting the potential multiplicity of MAPH. The technology has the potential to simplify copy number assays for genes with a large number of exons, or of expanded sets of probes from dispersed genomic locations.</p>http://www.biomedcentral.com/1471-2164/7/163
spellingShingle Chan Alan
Wu Ying
Datta Parikkhit
Gibbons Brian
AL Armour John
Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA
BMC Genomics
title Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA
title_full Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA
title_fullStr Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA
title_full_unstemmed Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA
title_short Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA
title_sort microarray maph accurate array based detection of relative copy number in genomic dna
url http://www.biomedcentral.com/1471-2164/7/163
work_keys_str_mv AT chanalan microarraymaphaccuratearraybaseddetectionofrelativecopynumberingenomicdna
AT wuying microarraymaphaccuratearraybaseddetectionofrelativecopynumberingenomicdna
AT dattaparikkhit microarraymaphaccuratearraybaseddetectionofrelativecopynumberingenomicdna
AT gibbonsbrian microarraymaphaccuratearraybaseddetectionofrelativecopynumberingenomicdna
AT alarmourjohn microarraymaphaccuratearraybaseddetectionofrelativecopynumberingenomicdna